These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 28830791)

  • 21. Locoregional Confinement and Major Clinical Benefit of
    Séhédic D; Chourpa I; Tétaud C; Griveau A; Loussouarn C; Avril S; Legendre C; Lepareur N; Wion D; Hindré F; Davodeau F; Garcion E
    Theranostics; 2017; 7(18):4517-4536. PubMed ID: 29158842
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sustained Delivery of Doxorubicin via Acetalated Dextran Scaffold Prevents Glioblastoma Recurrence after Surgical Resection.
    Graham-Gurysh E; Moore KM; Satterlee AB; Sheets KT; Lin FC; Bachelder EM; Miller CR; Hingtgen SD; Ainslie KM
    Mol Pharm; 2018 Mar; 15(3):1309-1318. PubMed ID: 29342360
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Penetrative and Sustained Drug Delivery Using Injectable Hydrogel Nanocomposites for Postsurgical Brain Tumor Treatment.
    Kang T; Cha GD; Park OK; Cho HR; Kim M; Lee J; Kim D; Lee B; Chu J; Koo S; Hyeon T; Kim DH; Choi SH
    ACS Nano; 2023 Mar; 17(6):5435-5447. PubMed ID: 36926815
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of the distribution, retention, and efficacy of internal radiation of
    Cikankowitz A; Clavreul A; Tétaud C; Lemaire L; Rousseau A; Lepareur N; Dabli D; Bouchet F; Garcion E; Menei P; Couturier O; Hindré F
    J Neurooncol; 2017 Jan; 131(1):49-58. PubMed ID: 27783195
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Codelivery of paclitaxel and temozolomide through a photopolymerizable hydrogel prevents glioblastoma recurrence after surgical resection.
    Zhao M; Bozzato E; Joudiou N; Ghiassinejad S; Danhier F; Gallez B; Préat V
    J Control Release; 2019 Sep; 309():72-81. PubMed ID: 31306678
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Local release of gemcitabine via in situ UV-crosslinked lipid-strengthened hydrogel for inhibiting osteosarcoma.
    Wu W; Dai Y; Liu H; Cheng R; Ni Q; Ye T; Cui W
    Drug Deliv; 2018 Nov; 25(1):1642-1651. PubMed ID: 30799654
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting of immunosuppressive myeloid cells from glioblastoma patients by modulation of size and surface charge of lipid nanocapsules.
    Pinton L; Magri S; Masetto E; Vettore M; Schibuola I; Ingangi V; Marigo I; Matha K; Benoit JP; Della Puppa A; Bronte V; Lollo G; Mandruzzato S
    J Nanobiotechnology; 2020 Feb; 18(1):31. PubMed ID: 32066449
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Temozolomide-loaded photopolymerizable PEG-DMA-based hydrogel for the treatment of glioblastoma.
    Fourniols T; Randolph LD; Staub A; Vanvarenberg K; Leprince JG; Préat V; des Rieux A; Danhier F
    J Control Release; 2015 Jul; 210():95-104. PubMed ID: 25982679
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The use of TMZ embedded hydrogels for the treatment of orthotopic human glioma xenografts.
    Adhikari B; Li J; Brandel MG; Futalan D; Akers J; Deming T; Chen CC; Carter BS
    J Clin Neurosci; 2017 Nov; 45():288-292. PubMed ID: 28867360
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low dose gemcitabine-loaded lipid nanocapsules target monocytic myeloid-derived suppressor cells and potentiate cancer immunotherapy.
    Sasso MS; Lollo G; Pitorre M; Solito S; Pinton L; Valpione S; Bastiat G; Mandruzzato S; Bronte V; Marigo I; Benoit JP
    Biomaterials; 2016 Jul; 96():47-62. PubMed ID: 27135716
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lipid-Core Nanocapsules Act as a Drug Shuttle Through the Blood Brain Barrier and Reduce Glioblastoma After Intravenous or Oral Administration.
    Rodrigues SF; Fiel LA; Shimada AL; Pereira NR; Guterres SS; Pohlmann AR; Farsky SH
    J Biomed Nanotechnol; 2016 May; 12(5):986-1000. PubMed ID: 27305820
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug-loaded implantable surgical cavity-adaptive hydrogels for prevention of local tumor recurrence.
    Zhuang B; Chen T; Xiao Z; Jin Y
    Int J Pharm; 2020 Mar; 577():119048. PubMed ID: 31978462
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacological Improvement and Preclinical Evaluation of Methotrexate-Loaded Lipid-Core Nanocapsules in a Glioblastoma Model.
    Figueiró F; de Oliveira CP; Rockenbach L; Mendes FB; Bergamin LS; Jandrey EH; Edelweiss MI; Guterres SS; Pohlmann AR; Battastini AM
    J Biomed Nanotechnol; 2015 Oct; 11(10):1808-18. PubMed ID: 26502643
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Continuous iontronic chemotherapy reduces brain tumor growth in embryonic avian in vivo models.
    Handl V; Waldherr L; Arbring Sjöström T; Abrahamsson T; Seitanidou M; Erschen S; Gorischek A; Bernacka-Wojcik I; Saarela H; Tomin T; Honeder SE; Distl J; Huber W; Asslaber M; Birner-Grünberger R; Schäfer U; Berggren M; Schindl R; Patz S; Simon DT; Ghaffari-Tabrizi-Wizsy N
    J Control Release; 2024 May; 369():668-683. PubMed ID: 38548064
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeting and treatment of glioblastomas with human mesenchymal stem cells carrying ferrociphenol lipid nanocapsules.
    Clavreul A; Montagu A; Lainé AL; Tétaud C; Lautram N; Franconi F; Passirani C; Vessières A; Montero-Menei CN; Menei P
    Int J Nanomedicine; 2015; 10():1259-71. PubMed ID: 25709447
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Encapsulation of Temozolomide in a Calixarene Nanocapsule Improves Its Stability and Enhances Its Therapeutic Efficacy against Glioblastoma.
    Renziehausen A; Tsiailanis AD; Perryman R; Stylos EK; Chatzigiannis C; O'Neill K; Crook T; Tzakos AG; Syed N
    Mol Cancer Ther; 2019 Sep; 18(9):1497-1505. PubMed ID: 31213505
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Afatinib and Temozolomide combination inhibits tumorigenesis by targeting EGFRvIII-cMet signaling in glioblastoma cells.
    Vengoji R; Macha MA; Nimmakayala RK; Rachagani S; Siddiqui JA; Mallya K; Gorantla S; Jain M; Ponnusamy MP; Batra SK; Shonka N
    J Exp Clin Cancer Res; 2019 Jun; 38(1):266. PubMed ID: 31215502
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Micro-Environment Regulator for Filling the Clinical Treatment Gap after a Glioblastoma Operation.
    Zhang Y; You H; Wang Y; Chen Q; Guo Q; Chu Y; Li C; Zhou W; Chen H; Liu P; Wang Y; Zhao Z; Zhou Z; Luo Y; Li X; Zhang T; Song H; Li C; Su B; Sun T; Bi Y; Yu L; Jiang C
    Adv Healthc Mater; 2022 Feb; 11(3):e2101578. PubMed ID: 34800085
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preirradiation gemcitabine chemotherapy for newly diagnosed glioblastoma. A phase II study.
    Weller M; Streffer J; Wick W; Kortmann RD; Heiss E; Küker W; Meyermann R; Dichgans J; Bamberg M
    Cancer; 2001 Jan; 91(2):423-7. PubMed ID: 11180090
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functionalized nanogels carrying an anticancer microRNA for glioblastoma therapy.
    Shatsberg Z; Zhang X; Ofek P; Malhotra S; Krivitsky A; Scomparin A; Tiram G; Calderón M; Haag R; Satchi-Fainaro R
    J Control Release; 2016 Oct; 239():159-68. PubMed ID: 27569663
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.